433 related articles for article (PubMed ID: 22991406)
1. Lost in translation: examining patient and physician perceptions of implantable cardioverter-defibrillator deactivation discussions.
Mitar M; Alba AC; MacIver J; Ross H
Circ Heart Fail; 2012 Sep; 5(5):660-6. PubMed ID: 22991406
[No Abstract] [Full Text] [Related]
2. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
Herman D; Stros P; Curila K; Kebza V; Osmancik P
Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
[TBL] [Abstract][Full Text] [Related]
3. Management of patients with ICDs at the end of life (EOL): a qualitative study.
Kelley AS; Mehta SS; Reid MC
Am J Hosp Palliat Care; 2008 Dec-2009 Jan; 25(6):440-6. PubMed ID: 18812618
[TBL] [Abstract][Full Text] [Related]
4. Managing with pacemakers and implantable cardioverter defibrillators.
Lampert R
Circulation; 2013 Oct; 128(14):1576-85. PubMed ID: 24081953
[No Abstract] [Full Text] [Related]
5. Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?
Waterhouse E; Ahmad F
Curr Opin Support Palliat Care; 2011 Dec; 5(4):307-11. PubMed ID: 22025091
[TBL] [Abstract][Full Text] [Related]
6. Posttraumatic stress and the implantable cardioverter-defibrillator patient: what the electrophysiologist needs to know.
Sears SF; Hauf JD; Kirian K; Hazelton G; Conti JB
Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):242-50. PubMed ID: 21505176
[No Abstract] [Full Text] [Related]
7. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use].
Francia P; Cappato R
G Ital Cardiol (Rome); 2011 May; 12(5):379-82; discussion 382. PubMed ID: 21593958
[No Abstract] [Full Text] [Related]
8. The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives.
Daeschler M; Verdino RJ; Kirkpatrick JN
Europace; 2017 Aug; 19(8):1343-1348. PubMed ID: 27915265
[TBL] [Abstract][Full Text] [Related]
9. Ethical issues on defibrillator deactivation in end-of-life patients.
Facciorusso A; Stanislao M; Fanelli M; Valori VM; Valle G
J Cardiovasc Med (Hagerstown); 2011 Jul; 12(7):498-500. PubMed ID: 21610508
[No Abstract] [Full Text] [Related]
10. Improving Communication in Heart Failure Patient Care.
Goldstein NE; Mather H; McKendrick K; Gelfman LP; Hutchinson MD; Lampert R; Lipman HI; Matlock DD; Strand JJ; Swetz KM; Kalman J; Kutner JS; Pinney S; Morrison RS
J Am Coll Cardiol; 2019 Oct; 74(13):1682-1692. PubMed ID: 31558252
[TBL] [Abstract][Full Text] [Related]
11. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
[TBL] [Abstract][Full Text] [Related]
12. An unusual case of impossible communication between an ICD and programmer.
Attanasio P; Wutzler A; Huemer M; Parwani AS; Boldt LH; Haverkamp W; Blaschke F
J Cardiovasc Electrophysiol; 2015 Feb; 26(2):230. PubMed ID: 25257919
[No Abstract] [Full Text] [Related]
13. [Deactivation of implantable defibrillators--also an ethical issue. Written routines of the process are necessary as illustrated by the described case report].
Carlsson J; Mansson A; Olsson D
Lakartidningen; 2011 Mar 9-15; 108(10):536-9. PubMed ID: 21744554
[No Abstract] [Full Text] [Related]
14. Effective communication and ethical consent in decisions related to ICDs.
Clark AM; Jaarsma T; Strachan P; Davidson PM; Jerke M; Beattie JM; Duncan AS; Ski CF; Thompson DR
Nat Rev Cardiol; 2011 Jul; 8(12):694-705. PubMed ID: 21788961
[TBL] [Abstract][Full Text] [Related]
15. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
[TBL] [Abstract][Full Text] [Related]
16. Shared Decision-Making About End-of-Life Care Scenarios Compared Among Implantable Cardioverter Defibrillator Patients: A National Cohort Study.
Thompson JH; Thylén I; Moser DK
Circ Heart Fail; 2019 Oct; 12(10):e005619. PubMed ID: 31601115
[TBL] [Abstract][Full Text] [Related]
17. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
Kuck KH
Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
[No Abstract] [Full Text] [Related]
18. Patients, intimate partners and family experiences of implantable cardioverter defibrillators: qualitative systematic review.
Palacios-Ceña D; Losa-Iglesias ME; Alvarez-López C; Cachón-Pérez M; Reyes RA; Salvadores-Fuentes P; Fernández-de-Las-Peñas C
J Adv Nurs; 2011 Dec; 67(12):2537-50. PubMed ID: 21615459
[TBL] [Abstract][Full Text] [Related]
19. Magical thinking around end of life: An editorial on 'Implantable Cardioverter Defibrillator deactivation discussions: Reality vs. recommendations'.
MacKenzie MA
Eur J Cardiovasc Nurs; 2016 Feb; 15(1):8-9. PubMed ID: 26791007
[No Abstract] [Full Text] [Related]
20. [Implantable cardioverter-defibrillator deactivation at the end of life: ethical, clinical and communication issues].
Romanò M; Piga MA; Bertona R; Negro R; Ruggeri C; Zorzoli F; Villani R
G Ital Cardiol (Rome); 2017 Feb; 18(2):139-149. PubMed ID: 28398367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
